Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A 2A receptor...

Area of Science:

• Neuropharmacology
• Molecular Biology
• Genomics

Background:

• Caffeine is the world's most consumed psychoactive substance.
• Its complex actions in the brain are not fully understood.
• Identifying caffeine's molecular targets is crucial for understanding its effects.

Purpose of the Study:

• To uncover the multiple molecular targets of caffeine.
• To investigate the role of adenosine A(2A) receptors (A(2A)Rs) in caffeine's effects.
• To elucidate caffeine's dose-dependent impact on striatal gene expression.

Main Methods:

• Utilized a novel drug target validation strategy combining adenosine A(2A) receptor (A(2A)R) knockout (KO) mice and microarray profiling.
• Administered caffeine at different doses (10 mg/kg and 50 mg/kg) to wild-type (WT) and A(2A)R KO mice.
• Analyzed striatal gene expression patterns and employed Gene Set Enrichment Analysis.

Main Results:

• Caffeine's striatal gene expression effects are dose-dependent and involve multiple targets.
• A(2A)Rs are necessary but not sufficient for low-dose caffeine's effects.
• High-dose caffeine elicits complex expression patterns involving A(2A)Rs, non-A(2A)R pathways (PDE, GABA(A)R), and adipocyte differentiation/insulin signaling.

Conclusions:

• Caffeine interacts with multiple molecular targets in the brain, including A(2A)Rs and other pathways.
• Dose-dependent effects reveal distinct gene expression profiles and cellular pathways.
• These findings provide molecular insights into caffeine's acute pharmacological actions.